Skip to content

The effectiveness of transcranial direct current stimulation on the clinical outcomes of chronic migraine patients

Comparison of the effectiveness of transcranial direct current stimulation with three approaches, anodal occipital cortex, cathodic occipital cortex and sham on clinical outcomes in patients with chronic migraine

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20100501003844N5
Enrollment
144
Registered
2023-02-15
Start date
2023-03-21
Completion date
Unknown
Last updated
2023-03-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Migraine patients. Migraine

Interventions

Intervention 1: Intervention group: Occipital cortex anodal tDCS group? the anode electrode is placed on the occipital cortex on the dominant side of the pain and the cathode on the chin on the opposi

Sponsors

Rasht University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Patients with chronic migraine Resistant to drug treatments Those who experience frequent migraine attacks Experienced at least 4 attacks per month or 8 days of migraine attacks per month

Exclusion criteria

Exclusion criteria: History of neurological diseases History of mental disorder and use of antipsychotic and antidepressant drugs History of treatment with tDCS or other brain stimulation techniques Taking drugs that block voltage-dependent sodium and calcium channels Failure of the patient to continue participating in the study

Design outcomes

Primary

MeasureTime frame
Number of migraine days per month, pain intensity, frequency of taking painkillers. Timepoint: Before the start of the intervention, after the last session of the intervention and two months after. Method of measurement: Based on questions from the patient.

Secondary

MeasureTime frame
Intensity of pain. Timepoint: Before the start of the intervention, after the last session of the intervention and two months after. Method of measurement: Using Visual Analogue Scale(VAS), according to patient report.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactCyrus Amir Alavi

Rasht University of Medical Sciences

cyrusemiralavi@yahoo.com+98 13 3336 8814

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026